Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Murray

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
Leukemia|January 29, 2022
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Frontiers in Oncology|January 10, 2022
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA DamageSams M A Sadat, Melinda Wuest, Igor M Paiva, et al.
Organic Letters|February 7, 2017
Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic DesymmetrizationMark McLaughlin, Jongrock Kong, Kevin M Belyk, et al.
Clinical Trials (London, England)|May 16, 2019
Addressing guideline and policy changes during pragmatic clinical trialsLesley H Curtis, Laura M Dember, Miguel A Vazquez, et al.
Clinical Chemistry and Laboratory Medicine|October 20, 2020
Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down <i>de novo</i> sequencingW Ian Deighan, Valerie J Winton, Rafael D Melani, et al.
BMJ Open|June 30, 2022
Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trialCerys Joyce Tassinari, Ruchi Higham, Isabelle Louise Smith, et al.
Journal of Medicinal Chemistry|March 8, 2002
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeletonStephen Connolly, Colin Bennion, Sarah Botterell, et al.
Leukemia|June 17, 2024
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Biological Reviews of the Cambridge Philosophical Society|February 22, 2021
Meiosis and beyond - understanding the mechanistic and evolutionary processes shaping the germline genomeRoberta Bergero, Peter Ellis, Wilfried Haerty, et al.
Trials|December 2, 2025
SurfON trial: study protocol for a multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distressElaine M Boyle, Vasha Bari, Peter J Bradley, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Leukemia|January 29, 2022
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Frontiers in Oncology|January 10, 2022
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA DamageSams M A Sadat, Melinda Wuest, Igor M Paiva, et al.
Organic Letters|February 7, 2017
Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic DesymmetrizationMark McLaughlin, Jongrock Kong, Kevin M Belyk, et al.
Clinical Trials (London, England)|May 16, 2019
Addressing guideline and policy changes during pragmatic clinical trialsLesley H Curtis, Laura M Dember, Miguel A Vazquez, et al.
Clinical Chemistry and Laboratory Medicine|October 20, 2020
Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down <i>de novo</i> sequencingW Ian Deighan, Valerie J Winton, Rafael D Melani, et al.
BMJ Open|June 30, 2022
Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trialCerys Joyce Tassinari, Ruchi Higham, Isabelle Louise Smith, et al.
Journal of Medicinal Chemistry|March 8, 2002
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeletonStephen Connolly, Colin Bennion, Sarah Botterell, et al.
Leukemia|June 17, 2024
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumabNadine Abdallah, David Murray, Angela Dispenzieri, et al.
Biological Reviews of the Cambridge Philosophical Society|February 22, 2021
Meiosis and beyond - understanding the mechanistic and evolutionary processes shaping the germline genomeRoberta Bergero, Peter Ellis, Wilfried Haerty, et al.
Trials|December 2, 2025
SurfON trial: study protocol for a multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distressElaine M Boyle, Vasha Bari, Peter J Bradley, et al.
Pageof 33